Download PDF
Dtsch Med Wochenschr 2012; 137(40): 2014-2017
DOI: 10.1055/s-0032-1305291
Intensivmedizin | Commentary
Intensivmedizin, Pneumologie
© Georg Thieme Verlag KG Stuttgart · New York

Akute schwere Lungenembolie

Acute massive pumonary embolism
S. Konstantinides
1   Centrum für Thrombose und Hämostase, Universitätsmedizin Mainz
› Author Affiliations
Further Information

Publication History

Publication Date:
28 September 2012 (online)

Also available at
    Permissions and Reprints

Schlüsselwörter

Lungenembolie - Risikostratifizierung - Thrombolyse - Thrombektomie - Antikoagulation

Keywords

pulmonary embolism - risk stratification - thrombolysis - thrombectomy - anticoagulation
 

  • Literatur

  • 1 Anderson Jr FA, Wheeler HB, Goldberg RJ et al. A population-based perspective of the hospital incidence and case- fatality rates of deep vein thrombosis and pulmonary embolism. The Worcester DVT Study. Arch Intern Med 1991; 151: 933-938
    CrossrefPubMedGoogle Scholar
  • 2 Buller HR, Prins MH, Lensin AW et al. Oral rivaroxaban for the treatment of symptomatic pulmonary embolism. N Engl J Med 2012; 366: 1287-1297
    CrossrefPubMedGoogle Scholar
  • 3 Carrier M, Le GG, Wells PS et al. Systematic review: case-fatality rates of recurrent venous thromboembolism and major bleeding events among patients treated for venous thromboembolism. Ann Intern Med 2010; 152: 578-589
    CrossrefPubMedGoogle Scholar
  • 4 Cohen AT, Agnelli G, Anderson FA et al. Venous thromboembolism (VTE) in Europe. The number of VTE events and associated morbidity and mortality. Thromb Haemost 2007; 98: 756-764
    Article in Thieme ConnectPubMedGoogle Scholar
  • 5 Goldhaber SZ, Visani L, De Rosa M. Acute pulmonary embolism: clinical outcomes in the International Cooperative Pulmonary Embolism Registry (ICOPER). Lancet 1999; 353: 1386-1389
    CrossrefPubMedGoogle Scholar
  • 6 Interdisziplinäre S2-Leitlinie. Diagnostik und Therapie der Bein- und Beckenvenenthrombose und der Lungenembolie. VASA 2010; 39: 1-39
    CrossrefPubMedGoogle Scholar
  • 7 Jaff MR, McMurtry MS, Archer SL et al. Management of massive and submassive pulmonary embolism, iliofemoral deep vein thrombosis, and chronic thromboembolic pulmonary hypertension: a scientific statement from the American Heart Association. Circulation 2011; 123: 1788-1830
    CrossrefPubMedGoogle Scholar
  • 8 Kearon C, Akl EA, Comerota AJ et al. Antithrombotic Therapy for VTE Disease: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed. American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest 2012; 141: e419S-e494S
    CrossrefPubMedGoogle Scholar
  • 9 Konstantinides S, Janssens U, Mayer E. Pocket-Leitlinien: Diagnostik und Therapie der akuten Lungenembolie. www.dgk.org
    PubMedGoogle Scholar
  • 10 Kuo WT, Gould MK, Louie JD et al. Catheter-directed therapy for the treatment of massive pulmonary embolism: systematic review and meta-analysis of modern techniques. J Vasc Interv Radiol 2009; 20: 1431-1440
    CrossrefPubMedGoogle Scholar
  • 11 Laporte S, Mismetti P, Decousus H et al. Clinical predictors for fatal pulmonary embolism in 15,520 patients with venous thromboembolism: findings from the Registro Informatizado de la Enfermedad TromboEmbolica venosa (RIETE) Registry. Circulation 2008; 117: 1711-1716
    CrossrefPubMedGoogle Scholar
  • 12 Oger E. Incidence of venous thromboembolism: a community-based study in Western France. EPI-GETBP Study Group. Groupe d'Etude de la Thrombose de Bretagne Occidentale. Thromb Haemost 2000; 83: 657-660
    Article in Thieme ConnectPubMedGoogle Scholar
  • 13 Schulman S, Kearon C, Kakkar AK et al. Dabigatran versus warfarin in the treatment of acute venous thromboembolism. N Engl J Med 2009; 361: 2342-2352
    CrossrefPubMedGoogle Scholar
  • 14 Silverstein MD, Heit JA, Mohr DN et al. Trends in the incidence of deep vein thrombosis and pulmonary embolism: a 25-year population-based study. Arch Intern Med 1998; 158: 585-593
    CrossrefPubMedGoogle Scholar
  • 15 Stein PD, Chenevert TL, Fowler SE et al. Gadolinium-enhanced magnetic resonance angiography for pulmonary embolism: a multicenter prospective study (PIOPED III). Ann Intern Med 2010; 152: 434-433
    CrossrefPubMedGoogle Scholar
  • 16 Stein PD, Matta F, Keyes DC et al. Impact of vena cava filters on in-hospital case fatality rate from pulmonary embolism. Am J Med 2012; 125: 478-484
    CrossrefPubMedGoogle Scholar
  • 17 Stein PD, Matta F, Steinberger DS et al. Intracerebral hemorrhage with thrombolytic therapy for acute pulmonary embolism. Am J Med 2012; 125: 50-56
    CrossrefPubMedGoogle Scholar
  • 18 Stein PD, Matta F. Thrombolytic therapy in unstable patients with acute pulmonary embolism: saves lives but underused. Am J Med 2012; 125: 465-470
    CrossrefPubMedGoogle Scholar
  • 19 The PEITHO Steering Committee. Single-bolus tenecteplase plus heparin compared with heparin alone for normotensive patients with acute pulmonary embolism who have evidence of right ventricular dysfunction and myocardial injury: rationale and design of the Pulmonary Embolism Thrombolysis (PEITHO) trial. Am Heart J 2012; 163: 33-38
    CrossrefPubMedGoogle Scholar
  • 20 Torbicki A, Perrier A, Konstantinides SV et al. Guidelines on the diagnosis and management of acute pulmonary embolism: The Task Force for the Diagnosis and Management of Acute Pulmonary Embolism of the European Society of Cardiology (ESC). Eur Heart J 2008; 29: 2276-2315
    CrossrefPubMedGoogle Scholar